Physician profile
Mikhail Romashko
NPI 1427407931
$1,421.46
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.13 · 2020: $430 · 2021: $640 · 2022: $197 · 2024: $66.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.54 | 2020-2022 | |
| Chiesi USA, INC. | $202.67 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $158.40 | 2019-2022 | |
| Astellas Pharma US INC | $154.99 | 2020 | |
| Amgen INC. | $154.84 | 2020-2022 | |
| Astrazeneca Pharmaceuticals Lp | $146.80 | 2020-2022 | |
| Abbott Laboratories | $135.46 | 2021 | |
| Ge Healthcare | $66.68 | 2024 | |
| Daiichi Sankyo INC. | $22.23 | 2022 | |
| Medtronic Vascular, INC. | $22.06 | 2019 | |
| Pfizer INC. | $21.79 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.46 | 2022 | |
| Amarin Pharma, INC. | $17.37 | 2019 | |
| Novo Nordisk INC | $16.59 | 2021 | |
| Esperion Therapeutics, INC. | $14.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mikhail Romashko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.